SofZia (Alcon, TX, USA), the most recent preservative ... such as those that are normally encountered in the tear film of the eye, the substance is deemed inactive. This is thought to induce ...

David Endicott, Alcon CEO World Sight Day 2024 focuses on the importance of eye care in young people. As the CEO of the ...

The first step to finding a better price for contact lenses is to find an affordable vision exam to get your prescription.

This includes the novel 1-week contact lens Precision-7, the next version of PanOptix, and the potential FDA approval of AR-15512 for dry eye treatment. Alcon’s management expects these new ...

The global ophthalmic devices market is fragmented and competitive, with leading players such as Alcon, Bausch Health Companies, Carl Zeiss Meditec AG, and Johnson & Johnson Vision leading this ...

Alcon Inc. (NYSE:ALC), a global leader in eye care products, finds itself at a critical juncture as it navigates a competitive landscape while leveraging its robust product pipeline. The company ...

SofZia™ is the most recent advancement in the field of ophthalmic preservatives and is the preservative system contained in one preparation of travoprost (Travatan Z ®, Alcon, Texas).

The Global Ophthalmic Devices Market is projected to reach USD 76.9 billion in 2024 and is expected to grow to USD 120.3 billion by 2033, with a CAGR of 5.1%. Ophthalmic device diagnose and treat ...

Advancements and Projections in the Ophthalmic Devices Market: Insights, Trends, Opportunities, and Recent DevelopmentsNew ...